217 related articles for article (PubMed ID: 16951476)
1. [Therapeutic effects of risedronate on Paget's disease of bone].
Takata S
Clin Calcium; 2006 Sep; 16(9):1508-12. PubMed ID: 16951476
[TBL] [Abstract][Full Text] [Related]
2. [Paget's disease of bone].
Takata S
Nihon Rinsho; 2006 Sep; 64(9):1724-30. PubMed ID: 16972687
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for diagnosis and management of Paget's disease of bone in Japan.
Takata S; Hashimoto J; Nakatsuka K; Yoshimura N; Yoh K; Ohno I; Yabe H; Abe S; Fukunaga M; Terada M; Zamma M; Ralston SH; Morii H; Yoshikawa H
J Bone Miner Metab; 2006; 24(5):359-67. PubMed ID: 16937267
[TBL] [Abstract][Full Text] [Related]
4. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
5. Midterm outcome of risedronate therapy for patients with Paget's disease of bone in the central part of Japan.
Nishida Y; Yamada Y; Tsukushi S; Sugiura H; Urakawa H; Ishiguro N
Clin Rheumatol; 2013 Feb; 32(2):241-5. PubMed ID: 23138882
[TBL] [Abstract][Full Text] [Related]
6. [Paget's disease of bone].
Saura R
Clin Calcium; 2007 Nov; 17(11):1769-72. PubMed ID: 17982199
[TBL] [Abstract][Full Text] [Related]
7. Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy.
Peris P; Alvarez L; Vidal S; Martínez MA; Monegal A; Guañabens N
Clin Exp Rheumatol; 2007; 25(2):206-10. PubMed ID: 17543143
[TBL] [Abstract][Full Text] [Related]
8. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
Whitson HE; Lobaugh B; Lyles KW
Bone; 2006 Oct; 39(4):954-8. PubMed ID: 16769264
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, tolerability, and safety of risedronate in Japanese patients with Paget's disease of bone.
Yoh K; Takata S; Yoshimura N; Hashimoto J
J Bone Miner Metab; 2010 Jul; 28(4):468-76. PubMed ID: 20179977
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological therapy of Paget's and other metabolic bone diseases.
Hosking D
Bone; 2006 Feb; 38(2 Suppl 2):S3-7. PubMed ID: 16406763
[TBL] [Abstract][Full Text] [Related]
11. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
Krane SM
Nat Clin Pract Rheumatol; 2006 Apr; 2(4):186-7. PubMed ID: 16932682
[No Abstract] [Full Text] [Related]
12. Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease.
Dunn CJ; Goa KL
Drugs; 2001; 61(5):685-712. PubMed ID: 11368289
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Paget's disease of the pelvis using F-18 FDG PET/CT.
Woo JH; Kim S; Choi SJ; Lee YH; Ji JD; Song GG
Int J Rheum Dis; 2010 Oct; 13(4):e51-4. PubMed ID: 21199453
[TBL] [Abstract][Full Text] [Related]
14. Paget's disease and bisphosphonates.
Rendina D; De Filippo G; Mossetti G
N Engl J Med; 2005 Dec; 353(24):2616-8; author reply 2616-8. PubMed ID: 16365936
[No Abstract] [Full Text] [Related]
15. [Pharmacological treatment of osteitis deformans (Paget's bone disease)].
Brixen KT; Abrahamsen B; Kassem MS; Mosekilde L
Ugeskr Laeger; 2005 Feb; 167(9):1009-12. PubMed ID: 15803994
[No Abstract] [Full Text] [Related]
16. A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group.
Miller PD; Brown JP; Siris ES; Hoseyni MS; Axelrod DW; Bekker PJ
Am J Med; 1999 May; 106(5):513-20. PubMed ID: 10335722
[TBL] [Abstract][Full Text] [Related]
17. The use of risedronate in Paget's disease.
Miller PD
Bone; 1999 May; 24(5 Suppl):91S-92S. PubMed ID: 10321937
[No Abstract] [Full Text] [Related]
18. [A young woman with headaches and skull anomalies: a long road to the diagnosis 'Paget's disease'].
Zillikens MC; Ginai AZ; Pols HA
Ned Tijdschr Geneeskd; 2006 Sep; 150(39):2150-4. PubMed ID: 17059090
[TBL] [Abstract][Full Text] [Related]
19. Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy.
Pirih FQ; Zablotsky M; Cordell K; McCauley LK
J Mich Dent Assoc; 2009 May; 91(5):38-43. PubMed ID: 19537656
[TBL] [Abstract][Full Text] [Related]
20. Risedronate: clinical usage.
Chapurlat RD; Delmas PD
Int J Clin Pract; 2001 May; 55(4):275-8. PubMed ID: 11406915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]